Skip to main navigation Skip to search Skip to main content

Proteases and protease inhibitors in cancer

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

The second conference on 'Proteases and protease inhibitors in cancer' was organized by the American Association for Cancer Research (AACR) and Acta Pathologica Microbiologica et Immunologica Scandinavica (APMIS). To understand the role of proteinases and to develop relevant synthetic inhibitors to stop or slow the progression of cancer, an integrated view on the role of proteinases and proteinase inhibitors is required. This is the main goal of this series of conferences. Approximately 300 people attended this conference, including many highly regarded scientists in the field. In total, 40 invited lectures were presented and 120 posters were displayed during two well-attended sessions
Original languageEnglish
Pages (from-to)517-522
JournalIDrugs
Volume1
Issue number5
Publication statusPublished - 1998

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Proteases and protease inhibitors in cancer'. Together they form a unique fingerprint.

Cite this